Open-Label, Non-Mandatory Transitioning From Originator Etanercept to Biosimilar SB4 Six-Month Results From a Controlled Cohort Study

Find Full text
Thumbnail
Fulltext:
195286.pdf
Embargo:
until further notice
Size:
283.7Kb
Format:
PDF
Description:
Publisher’s version
Publication year
2018
Author(s)
Tweehuysen, L
Huiskes, V.J.B.
Bemt, B.J.F van den
Vriezekolk, J.E.
Teerenstra, S.
Hoogen, F.H.J. van den
Ende, C.H.M. van den
Broeder, A.A. den
Source
Arthritis & Rheumatology, 70, 9, (2018), pp. 1408-1418
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/195286   https://hdl.handle.net/2066/195286
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.